Logo Image
|Articles|January 13, 2023

An Exciting Time in CDI: Approvals, Approaches and Anticipation

The therapies for Clostridioides difficile infection (CDI) saw many developments in recent months and there are more exciting things to come.


CDI saw quite a number of developments in 2022, especially with the approval of first-ever fecal microbiota, RBX2660, for C difficile recurrence at the end of the year.

There has been research looking at different approaches and the economics of CDI. In addition, there is another prospective approval pending for CDI this year.

Check out our slideshow to find more information on the approval, a differing approach, the economics of CDI, and what’s ahead.

To read the articles for the individual slides, click on the individual slides below:

Slide 1

Slide 2

Slide 3

Slide 4

Related to this article

View more
Asymptomatic C difficile Colonization in Infants Doesn’t Mean Benign
Asymptomatic C difficile Colonization in Infants Doesn’t Mean Benign
A new study in infants challenges the long-standing belief about the pathogen’s effects in the youngest pediatric population. Senior author Joseph Zackular, PhD, provides insights around his work including how it reshapes gut development and offers potential intervention strategies to shield neonates.
Read more
Peggy Lillis Foundation Will Honor C diff Advocates at Annual Gala
Peggy Lillis Foundation Will Honor C diff Advocates at Annual Gala
The Peggy Lillis Foundation will host its 17th Annual Changing the Odds Gala this month in New York City, and it will include a casino, fellowship amongst the C diff community, and an award ceremony honoring a physician-scientist, philanthropist, a researcher, and a patient advocate for their contributions to C difficile awareness, treatment, and prevention.
Read more
Measles Update: September 25, 2026
Measles Update: September 25, 2026
The latest CDC numbers show a 5.4% increase of measles cases from week-to-week. This year has already become the worst for the number of measles cases in the US since the disease was declared eliminated in 2000. With the start of respiratory virus season, case numbers are expected to continue to increase significantly.
Read more